This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- Alexander K.C. Leung, MD*
- Benjamin Barankin, MD†
- *Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada
- †Toronto Dermatology Centre, Toronto, Ontario, Canada
AUTHOR DISCLOSURE
Dr Leung has disclosed no financial relationships relevant to this article. Dr Barankin has disclosed that he attends advisory boards and gives continuing medical education talks for AbbVie, Actelion, Amgen, Celgene, Galderma, Janssen, La Roche Posay, Leo Pharma, Novartis, Pierre Fabre, SkinCeuticals, Tribute Pharma, and Valeant and that he receives support for clinical trials from Allergan, Amgen, AbbVie, Eli Lilly, Galderma, Janssen, and Leo Pharma. The commentary does not contain a discussion of an unapproved/investigative use of a commercial product/device.
Presentation
A 5-month-old girl presents with an abnormal hair pattern on the scalp that was first noted at birth. The infant is born at term to a gravida 2, para 1 28-year-old mother after an uncomplicated pregnancy and a normal vaginal delivery. There is no history of maternal use of medication during pregnancy. The infant’s birthweight is 3,200 g, length is 20.2 in (51.2 cm), and head circumference is 13.9 in (35.4 cm), each approximately at the 50th percentile. The neonatal course is uneventful. Her developmental milestones are normal. The parents are healthy and nonconsanguineous. There is no family history of craniospinal disorder or other similar disorders.
On …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.